Tirtsah Berger-Paskin

This inventor holds 6 USPTO granted patents. Top assignees: Technion Research & Development Foundation Ltd, Teva Pharmaceutical Industries Limited. Active years: 1995-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tirtsah Berger-Paskin. Retrieved from https://idiyas.com/inventor/tirtsah-berger-paskin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 7.3

ph-index = 6

Forward Citations = 270(Granted Patents)

Company Filing History:

6 out of 1,004

Technion Research & Development Foundation Ltd

patents

6 out of 505

Teva Pharmaceutical Industries Limited

patents

where one patent can have more than one assignee

Years Active: 1995-1998

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5786390 - Pharmaceutical compositions of the R-enantiomer of N-propargyl (1998-07-28),

2. 5668181 - Use of the R-enantiomers of N-propargyl-1-aminoindan compounds for the (1997-09-16),

3. 5532415 - R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses (1996-07-02),

4. 5457133 - R-enantiomers of N-propargyl-aminoindan compounds, their preparation and (1995-10-10),

5. 5453446 - Use of the R-enantiomers of N-propargyl 1-aminoindan compounds for (1995-09-26),

6. 5387612 - Use of the R-enantiomers of N-propargyl-1-aminoindan compounds for (1995-02-07),

Title: Tirtsah Berger-Paskin: Innovator in Pharmaceutical Compositions

Introduction

Tirtsah Berger-Paskin is a notable inventor based in Raanana, Israel. He has made significant contributions to the field of pharmaceuticals, holding a total of six patents. His work primarily focuses on the development of innovative pharmaceutical compositions.

Latest Patents

Among his latest patents is a pharmaceutical composition of the R-enantiomer of N-propargyl-1-aminoindan. This invention relates to the formulation of R(+)-N-propargyl-1-aminoindan and its pharmaceutically acceptable salts. Additionally, he has developed methods for the use of R(+)-N-propargyl-1-aminoindan compounds, showcasing his expertise in this area.

Career Highlights

Tirtsah has worked with prominent companies in the pharmaceutical industry, including Teva Pharmaceutical Industries Limited and Technion Research & Development Foundation Limited. His experience in these organizations has allowed him to advance his research and contribute to the development of new therapeutic solutions.

Collaborations

Throughout his career, Tirtsah has collaborated with esteemed colleagues, including John P. Finberg and Ruth Levy. These partnerships have played a crucial role in enhancing his research and expanding the impact of his inventions.

Conclusion

Tirtsah Berger-Paskin is a distinguished inventor whose work in pharmaceutical compositions has led to significant advancements in the field. His contributions continue to influence the development of innovative therapies.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]